- Home
- PLCE vs QNCX Comparison
PLCE vs QNCX Comparison
Compare PLCE & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLCE
- QNCX
- Stock Information
- Founded
- PLCE 1969
- QNCX 2012
- Country
- PLCE United States
- QNCX United States
- Employees
- PLCE N/A
- QNCX N/A
- Industry
- PLCE Clothing/Shoe/Accessory Stores
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLCE Consumer Discretionary
- QNCX Health Care
- Exchange
- PLCE Nasdaq
- QNCX Nasdaq
- Market Cap
- PLCE 97.5M
- QNCX 90.8M
- IPO Year
- PLCE 1997
- QNCX 2019
- Fundamental
- Price
- PLCE $4.68
- QNCX $1.54
- Analyst Decision
- PLCE Hold
- QNCX Strong Buy
- Analyst Count
- PLCE 1
- QNCX 6
- Target Price
- PLCE $6.00
- QNCX $8.00
- AVG Volume (30 Days)
- PLCE 432.8K
- QNCX 192.5K
- Earning Date
- PLCE 09-05-2025
- QNCX 08-11-2025
- Dividend Yield
- PLCE N/A
- QNCX N/A
- EPS Growth
- PLCE N/A
- QNCX N/A
- EPS
- PLCE N/A
- QNCX N/A
- Revenue
- PLCE $1,360,516,000.00
- QNCX N/A
- Revenue This Year
- PLCE N/A
- QNCX N/A
- Revenue Next Year
- PLCE $1.47
- QNCX N/A
- P/E Ratio
- PLCE N/A
- QNCX N/A
- Revenue Growth
- PLCE N/A
- QNCX N/A
- 52 Week Low
- PLCE $3.66
- QNCX $0.64
- 52 Week High
- PLCE $19.74
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- PLCE 49.98
- QNCX 41.55
- Support Level
- PLCE $4.32
- QNCX $1.59
- Resistance Level
- PLCE $4.89
- QNCX $1.62
- Average True Range (ATR)
- PLCE 0.27
- QNCX 0.11
- MACD
- PLCE 0.04
- QNCX -0.02
- Stochastic Oscillator
- PLCE 65.71
- QNCX 4.88
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.